Rating Rationale
July 01, 2020 | Mumbai
ZCL Chemicals Limited
 
Rating Action
Total Bank Loan Facilities Rated Rs.97 Crore
Long Term Rating CRISIL A-/Stable
Short Term Rating CRISIL A2+
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISILs ratings on bank facilities of ZCL Chemicals Limited (ZCL) continues to reflect company's strong financial risk profile marked by comfortable capital structure, controlled indebtedness (ratio of total outside liabilities to adjusted networth; TOLANW), and adequate debt protection metrics. The ratings also factor the company's established market position. These strengths are partially offset by moderate scale of operations and working capital intensive nature of operations.
 
The measures taken by various central and state governments towards containment of COVID-19 are not expected to impact the business risk profile of ZCL, as the company's operations are classified as essential with major presence in export market and plant is operational.

Key Rating Drivers & Detailed Description
Strengths:
* Strong financial profile: TOLANW estimated at 0.2 time as on March 31, 2020 on a networth base estimated at around Rs 415 crore represents healthy capital structure. Debt protection metrics were robust with interest coverage and net cash accruals to total debt of about 45 times and 2.66 times respectively during fiscal 2020. Company's financial risk profile is expected to remain healthy and low gearing provides healthy flexibility in terms of availing debt. 
 
* Established market position: Company has established its market position and specializes in manufacturing of advanced intermediates and active pharma ingredients (API). Company's market positon is also backed by promoter's extensive industry experience of over three decades, their strong understanding of market dynamics, and healthy relations with customers and suppliers. Over the years, company has developed a strong product portfolio backed by multiple process patents which has helped company to build diversified product basket. Company's plants have approvals such as WHO GMP certification, USFDA amongst others.
 
Weaknesses:
* Moderate scale of operations: Although on improving trend, company's scale of operations continues to remain moderate estimated at Rs 257 crore in fiscal 2020. In fiscal 2017, company had seen significant decline in revenue and operating profits, due to high reliance on single product. However, backed by product diversification, company's revenue is expected to improve as seen in fiscal 2020. Sustained growth in scale with sustained profitability will be a key rating sensitivity.
 
* Working capital intensive nature of operations: ZCL's operations are working capital intensive as indicated by quarterly average debtors and inventory of 93 and 95 days, respectively during fiscal 2020. Working capital requirement is partly explained by seasonality with higher sales during last quarter of financial year. Working capital cycle is expected to remain at similar levels.
Liquidity Strong

Company has strong liquidity indicated by cash and cash equivalents along with liquid investments of over Rs 216 crore as on March 31, 2020. Company has access to fund based limits of Rs 20 Cr which are utilized at an average of 38% for last 12 months ended April 2020. Company is expected to generate net cash accruals of around Rs 65-75 crore each in fiscal 2021 and fiscal 2022 adequate to meet term debt repayment obligations of Rs 13.6 crore and Rs 1.3 crore, respectively. Company is estimated to have healthy current ratio of over 5 times as on March 31, 2020. Company is not expected to have major debt funded capex plans in fiscal 2021. CRISIL believes the company has sufficient accruals, cash and cash equivalents and cushion in bank limits to meet its incremental working capital needs and repayments over the medium term, in absence of any definite organic or inorganic investment plan.

Outlook: Stable

CRISIL believes ZCL will continue to benefit from its established market position and healthy financial risk profile. 

Rating Sensitivity factors
Upward factor
* Increase in revenue and maintained operating margin resulting in cash accruals above Rs 60 crore on sustained basis
* Sustenance of financial risk profile, especially capital structure and debt protection metrics
 
Downward factor
* Decline in cash accrual below Rs 35 crore on account of subdued operating performance
* Larger-than-expected, debt-funded capital expenditure or in cases of stretch in working capital cycle, results in deterioration of financial risk profile
About the Company

ZCL, incorporated in 1991, manufactures and exports API's and advanced intermediates. The company is promoted by Dr. Ajay Parikh and its facilities are located at Ankleshwar (Gujarat).

Key Financial Indicators
As on/for the period ended March 31 Unit 2019 2018
Operating income Rs.Crore 188.27 169.28
Reported profit after tax Rs.Crore 32.61 29.77
PAT margins % 17.3 17.6
Adjusted Debt/Adjusted Networth Times 0.12 0.16
Interest coverage Times 21.83 19.38

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments and are included (where applicable) in the Annexure -- Details of Instrument in this Rating Rationale. For more details on the CRISIL complexity levels, please visit www.crisil.com/complexity-levels.
Annexure - Details of Instrument(s)
ISIN Name of Instrument Date of Allotment Coupon rate (%) Maturity Date Issue size (Rs.Cr) Complexity level Rating Assigned
with Outlook
NA Long Term Loan NA NA Jun-21 15 NA CRISIL A-/Stable
NA Proposed Long Term
Bank Loan Facility
NA NA NA 46 NA CRISIL A-/Stable
NA Proposed Short Term
Bank Loan Facility
NA NA NA 1 NA CRISIL A2+
NA Proposed Working
Capital Facility
NA NA NA 10 NA CRISIL A-/Stable
NA Working Capital Facility NA NA NA 25 NA CRISIL A-/Stable
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  97.00  CRISIL A-/Stable/ CRISIL A2+  29-05-20  CRISIL A-/Stable/ CRISIL A2+  28-02-19  CRISIL A-/Stable/ CRISIL A2+      24-11-17  CRISIL A-/Stable/ CRISIL A2+  CRISIL A-/Stable/ CRISIL A2+ 
Non Fund-based Bank Facilities  LT/ST          28-02-19  CRISIL A2+      24-11-17  CRISIL A2+  CRISIL A2+ 
All amounts are in Rs.Cr.
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Long Term Loan 15 CRISIL A-/Stable Long Term Loan 15 CRISIL A-/Stable
Proposed Long Term Bank Loan Facility 46 CRISIL A-/Stable Proposed Long Term Bank Loan Facility 46 CRISIL A-/Stable
Proposed Short Term Bank Loan Facility 1 CRISIL A2+ Proposed Short Term Bank Loan Facility 1 CRISIL A2+
Proposed Working Capital Facility 10 CRISIL A-/Stable Proposed Working Capital Facility 15 CRISIL A-/Stable
Working Capital Facility 25 CRISIL A-/Stable Working Capital Facility 20 CRISIL A-/Stable
Total 97 -- Total 97 --
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings
CRISILs Criteria for rating short term debt
The Rating Process
Understanding CRISILs Ratings and Rating Scales

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Rahul Guha
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8320
rahul.guha@crisil.com


Jumana Badshah
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 8324
Jumana.Badshah@crisil.com


Rushabh Borkar
Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8302
Rushabh.Borkar@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL